Finesse Reports on Cell World 2014 Shanghai

After the forum, Dr. Barbara Paldus, CEO of Finesse Solutions, gave an interview to Bio Equipment. She noted that Asia accounts for 25% of Finesse global business and is growing rapidly in this region, especially in China. CellWorld Shanghai was organized to serve this large market and has become a routine event in China. It provides an excellent opportunity for Finesse Solutions to meet customers and introduce new products. Dr. Paldus anticipates that CellWorld 2015 will be launched globally including the USA and Europe. CellWorld Shanghai will return in October 2015 and expects to welcome more than 100 delegates.

C Cubed Biotech to Represent Finesse Solutions

I am pleased to announce that I will be representing Finesse solutions in Northern California.   Finesse is a dynamic company that offers a wide range of solutions for advanced control of bioprocess systems.  They offer complete solutions for bioreactors including stirred tank single use systems, glass vessels, and rocker platforms, which are scalable from lab to process scale.  Finesse offers powerful Delta V ready solutions and has engineered a unique architecture around their DCS based control systems and TruBio software platform.  Finesse has designed advanced optics for more accurate and efficient single use sensors, extremely accurate pump technology, advanced gassing strategies, and the ability to rapidly integrate technologies from different suppliers.  They truly offer unique solutions that are dynamic and flexible.  

Visit the Finesse website for more information www.finesse.com

C Cubed Biotech Company Launch

I am pleased to announce that starting April 1st, 2014 I will be starting my new company C Cubed Biotech.  I will be representing RIM BIO, PAW Bioscience, and WaterSep in the Northern California Territory.  I am excited to be actively working with the Bay Area Biotech community and look forward to working with my friends and colleagues in the Bay Area to work on process development and manufacturing solutions.  I appreciate your support as I begin this new venture.

Regards,

Chris Connolly